DOTA (chelator)

From WikiMD's WELLNESSPEDIA

1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (also known as DOTA) is an organic compound that is used as a complexing agent, specifically as a chelator in medicine. It is a white, crystalline powder that is soluble in water and has a slightly acidic pH.

Chemical Structure[edit]

DOTA is a macrocyclic compound, which means it has a large, ring-shaped structure. It consists of a 12-membered ring containing four nitrogen atoms and four carboxylic acid groups. The nitrogen atoms and the carboxylic acid groups are able to bind to metal ions, forming a stable complex.

Medical Uses[edit]

In medicine, DOTA is used as a chelating agent in the preparation of radiopharmaceuticals. It is able to form stable complexes with a variety of metal ions, including those used in medical imaging and therapy, such as gallium-68, lutetium-177, and yttrium-90. These complexes can be used in positron emission tomography (PET) and single-photon emission computed tomography (SPECT) imaging, as well as in targeted radionuclide therapy.

Pharmacology[edit]

The pharmacology of DOTA is largely determined by the metal ion it is complexed with. The DOTA chelate acts as a carrier, delivering the metal ion to the desired location in the body. The properties of the metal ion, such as its radioactive decay and its interaction with biological tissues, determine the pharmacological effect.

Safety[edit]

DOTA is generally considered safe for use in humans. However, as with any medical procedure, there are potential risks and side effects. These can include allergic reactions, kidney damage, and radiation exposure. The risk of these side effects can be minimized by careful patient selection and monitoring.

See Also[edit]

References[edit]


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


DOTA (chelator)[edit]

  • Tetraxetan structure
    Tetraxetan structure
  • Y-90 tacatuzumab tetraxetan structure
    Y-90 tacatuzumab tetraxetan structure
  • Yttrium-90 edotreotide
    Yttrium-90 edotreotide
  • DOTATATE
    DOTATATE

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=DOTA_(chelator)&oldid=6625254"